Quest Diagnostics Incorporated (DGX) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Diagnostics & Research Branche. Der Hauptsitz des Unternehmens ist in Secaucus, NJ, United States. Der aktuelle CEO ist James E. Davis.
DGX hat IPO-Datum 1996-12-17, 55,000 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $21.49B.
Quest Diagnostics Incorporated is a leading provider of diagnostic testing, information, and services operating in the United States and internationally. The company delivers a comprehensive range of clinical laboratory services, including routine testing, advanced clinical testing, and anatomic pathology testing, serving patients, clinicians, hospitals, health plans, and employers through an extensive network of laboratories and patient service centers. Quest Diagnostics operates multiple diagnostic brands including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum, while also offering risk assessment services for the life insurance industry and healthcare information technology solutions to support clinical operations. Founded in 1967 and headquartered in Secaucus, New Jersey, the company leverages a diverse workforce of phlebotomists, nurses, and health professionals to deliver diagnostic information across multiple service channels.
